A rare CEO opportunity for a proven scientific-services leader who wants to build, acquire and scale – not simply inherit.
An investor-backed life sciences platform is seeking a Group CEO to transform a founder-led, sub-scale CRO into a broader, integrated and scientifically differentiated partner to leading pharma and biotech.
SCALE
Step-change revenue, EBIDTA & organizational maturity
US GROWTH
Build genuine in-country commercial presence
BUY & BUILD
Lead acquisitions and integrate to one platform
SCIENCE
Broaden capabilities and grow programme value
Your scope, responsibilities and accountabilities will include:
- Own strategy, performance, people and the Group P&L.
- Drive US market entry and convert relationships into larger, multi-service programmes.
- Lead UK and selective US M&A – from origination and evaluation through integration.
- Create one leadership team, one P&L and a scalable operating model.
- Shape the scientific roadmap while protecting quality, credibility and customer trust.
- Build the platform toward a compelling value-creation and exit story.
Ideally you will possess extensive experience, including:
- Scaled a preclinical, drug-discovery CRO or closely related scientific services business.
- Delivered meaningful customer-facing growth in the US biotech/pharma market.
- Executed acquisitions, built adjacent service lines and integrated businesses successfully.
- Led scientists and commercial teams with equal credibility.
- Operated hands-on in a scale-up environment with strong financial and KPI discipline.
- Investor-backed / private equity experience is highly desirable.
